Albuminuria - 109 Studies Found Completed : Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. : Diabetic Nephropathy Hypertension : 2013-08-13 : Drug: Green tea extract 200mg/capsule Administered orally 4 capsules per day For 3 months Completed : A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus : Diabetes Mellitus, Type 2 Albuminuria : 2013-10-17 : Drug: Placebo One placebo caps Completed : A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria : Type 2 Diabetes Mellitus : 2017-04-13 : Drug: metformin oral Terminated : Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study) : Chronic Kidney Disease, Unspecified : 2012-07-30 : Drug: Experimental arm Oral pa Completed : Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease : Chronic Kidney Disease Albuminuria : 2015-07-08 : Drug: Spironolactone Drug: Amiloride Completed : Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan : Chronic Kidney Disease Diabetic Nephropathy : 2011-08-25 : Drug: Atrasentan low dose group Completed : CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea : Diabetic Nephropathy Sleep Apnea : 2016-05-31 : Device: Continuous positive airway pressure Completed : A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria : Diabetic Nephropathy Type 2 Diabetes Mellitus : 2011-09-22 : Drug: Placebo Placebo capsules Completed : Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria : Hypertension Type II Diabetes Mellitus : 2007-11-19 : Drug: SPP635 oral once daily Completed : A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors : Chronic Kidney Disease Diabetic Nephropathy : 2009-06-11 : Drug: Placebo for Atrasentan 0.2 mg/mL solution <<< Previous | Next >>>
